Human T-cells recognise N-terminally Fmoc-modified peptide

Author： Mannering S.I.   Purcell A.W.   Honeyman M.C.   McCluskey J.   Harrison L.C.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.25, 2003-09, pp. : 3638-3646

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activation and functional capacity of human neonatal CD4 T-cells

By Reen D.J.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1401-1408

Elsevier

Access to resources Recommend Favorite

Application of murine T-T hybridoma cells to in vitro potency assay of human synthetic peptide vaccines

By Sheue C.T.Y.   Nag B.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1313-1321

Elsevier

Access to resources Recommend Favorite

Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host

By Jiang H.-Q.   Thurnheer M.C.   Zuercher A.W.   Boiko N.V.   Bos N.A.   Cebra J.J.  

Vaccine, Vol. 22, Iss. 7, 2004-02 ,pp. : 805-811

Elsevier

Access to resources Recommend Favorite

NK and NK/T cells in human senescence

By Solana R.   Mariani E.  

Vaccine, Vol. 18, Iss. 16, 2000-02 ,pp. : 1613-1620

Elsevier

Access to resources Recommend Favorite

Bovine T cells preferentially recognize non-viral spacer epitopes in a putative FMDV vaccinal peptide

By Glass E.J.   Millar P.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 225-229

Elsevier

Access to resources Recommend Favorite